Ventas, Inc.

▲ Bull Case

• ◆SHOP occupancy recovery from 88.6% to 93% adds ~$0.47 FFO/share — equivalent to 1.5 years of organic growth — with no acquisition capital required, driving FY2027E FFO to $3.95 and P/FFO re-rating toward sector fair 15–18x.
• ◆Baby Boomer 80+ cohort grows 58% from 2025–2035 (12M to 19M), creating a structural demand surge for senior housing that is supply-constrained through at least 2028, supporting sustained double-digit SHOP same-store NOI growth and eventual multiple expansion to 18x for an IG re-rate scenario implying $66.60/share.
• ◆Federal Reserve rate cuts of 50+ bps compress healthcare REIT cap rates, expanding NAV by 10–15%, while a confirmed CEO succession (Hutchens) removes the governance uncertainty premium and enables a re-rating toward Welltower-like multiples; GGM fair value at 6% perpetual growth implies $68.97/share (+38%).

▼ Bear Case

• ◆CEO Debra Cafaro's departure (26-year tenure) without Justin Hutchens confirmed as successor would likely cause a -15 to -20% dislocation as deal-flow relationships and institutional premium evaporate, materially impairing the acquisition-driven growth thesis.
• ◆10-year Treasury rising above 5.0% and holding for 90+ days compresses VTR's NAV by 10–20% and raises refinancing costs on $13.5B of debt, shifting the required return framework unfavorably even as the demographic tailwind remains intact.
• ◆SHOP occupancy plateau below 90% driven by labor inflation re-acceleration or recessionary demand softness collapses FY2027 FFO to $3.40–$3.50 from the base $3.95 estimate, eliminating the core occupancy-recovery thesis that justifies the current multiple.

“The central debate is whether VTR's 13.5x FY2026E P/FFO discount to Welltower reflects a justified structural scale gap or an exploitable mispricing driven by CEO succession overhang and rate sensitivity fears. Bulls argue the 20-consecutive-quarter SHOP occupancy trend, 58% growth in the 80+ cohort, and near-zero new supply through 2028 make the recovery durable and that VTR at 12.7x FY2027E P/FFO is priced as if the thesis stalls — contradicting both the demographic data and track record. Bears counter that Welltower's $90B+ market cap systematically advantages it in large deal flow, that Cafaro's eventual departure is a binary event risk with no clear succession timeline, and that $13.5B of debt makes VTR highly NAV-sensitive to any rate resurgence. The FFO yield debate (7.4% vs. Welltower's 4–6% fair range) encapsulates this: either VTR deserves to trade closer to WELL as occupancy normalizes, or the discount is permanent due to scale and governance.”

• ◆Q2 2026 earnings confirmation of SHOP same-store NOI growth for 5th consecutive double-digit year → multiple re-rates toward 15x FY2026E ($55+)
• ◆SHOP occupancy reaching 90%+ milestone (each 100bps = ~$0.11 FFO/share uplift)
• ◆Federal Reserve rate cuts of 50+ bps compressing healthcare REIT cap rates and expanding NAV 10–15%
• ◆CEO succession announcement with Justin Hutchens confirmed, removing governance uncertainty premium
• ◆M&A or strategic combination at premium to NAV

• ◆CEO Cafaro unexpected departure without Hutchens confirmed as successor → stock dislocation -15 to -20%; reduce 20%
• ◆10-year Treasury rises above 5.0% and holds 90+ days → NAV compression 10–20%; reduce 15%
• ◆SHOP same-store NOI growth below +5% for 2 consecutive quarters → FY2027 FFO collapses to $3.40–3.50; reduce 25%
• ◆Net Debt/EBITDA rises above 6.5x for 2 consecutive quarters → IG credit spread widens; reduce 20%
• ◆Welltower or large PE closes >$5B senior housing portfolio VTR competed for at materially lower cap rate → systematic deal-flow disadvantage confirmed; reduce 10%